Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
NCT00778063 is an interventional trial sponsored by Ochsner Health System. As of 18 Nov 2026, it was terminated. It studies Dexmedetomidine and Saline in Otitis Media. The registry lists an enrollment of 40 participants at 1 site in 1 country. The registry lists a start date of 30 Sept 2008 and a primary completion date of 31 Mar 2013.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00778063 |
| Status | Terminated |
| Study type | Interventional trial |
| Lead sponsor | Ochsner Health System |
| Enrollment | 40 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Otitis Media |
| Drugs | Dexmedetomidine and Saline |
| Start | 30 Sept 2008 |
| Primary completion | 31 Mar 2013 |
| Study completion | 31 Mar 2013 |
| Last update posted | 13 Apr 2023 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Dominic S Carollo, MD
Ochsner Health System
Study Director - Usha Ramadhyani, MD
Ochsner Health System
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ochsner Clinic Foundation
New Orleans
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT00778063
Each answer restates registry values shown on this page.
What is NCT00778063?
NCT00778063 is an interventional trial sponsored by Ochsner Health System. It studies Dexmedetomidine and Saline in Otitis Media.
Who leads NCT00778063?
The registry names Dominic S Carollo, MD (study director, Ochsner Health System) and Usha Ramadhyani, MD (principal investigator, Ochsner Health System) as overall officials.
Where does NCT00778063 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT00778063 study?
The registered drug and biological interventions are Dexmedetomidine and Saline.
When did NCT00778063 end?
The registry lists a primary completion date of 31 Mar 2013 and a study completion date of 31 Mar 2013. The sponsor last updated the record on 13 Apr 2023.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.